• Designing 40+ Hot Sessions of Scientific Forums, Dialogs and Roundtables
• Shooting for 200+ Oral Presentations in Whole Medicinal Chemistry
Fields
• Gathering 50+ Posters and Exhibitors in Cutting-edge Technologies and Novel Methods
• Bringing in 20+ Professional Media Supporters
• Experiencing a Cultural Atmosphere of Nanjing
|
Dr. Dave Madge, VP, Research Service Division, WuXi AppTec, Inc., China |
|
Dr. Jeff Reaga, Scientific Director, Amgen, USA |
|
Dr. Robert Plumb, Director of Metabolic Phenotyping and Stratified Medicine,Waters Corporation, USA |
|
Dr. Le Sun, President & CEO, AbMax Biotechnology, China |
|
Dr. Kiyoshi Nokihara, CEO & CSO, HiPep Laboratories, Japan |
|
Dr. Xian Bu, Co-Founder and Managing Director, SYNthesis med chem, USA |
|
Dr. Laure Bouchez, Director, Glenmark Therapeutics, USA |
|
Dr. Wei Zhang, Associate Professor, University of Massachusetts Boston, USA |
|
Dr. Jiren Zhang, Professor, Oncology Center, ZhuJiang Hospital of Southern Medical University, China |
|
Dr. Kevin Liu, Head of Chemistry, Global Discovery Chemistry, Novartis Institute of Biomedical Research, China |
|
Dr. Hakim Mohamed, President and CEO, Once Source Clinical & Management, USA |
|
Dr. Henrietta Ukwu, Senior Vice President, Head of Global Regulatory Affairs,Otsuka,USA |
|
Dr. Maode Lai, Academician of Nationale Akademie der Wissenschafte, President, China Pharmaceutical University, China |
|
Dr. Christopher Abell, Fellow of the Royal Society, Pro-Vice-Chancellor for Research,The University of Cambridge,UK |
|
Dr. Richard Soll, Senior Vice President and Head of International Discovery Service Unit,WuXi AppTec, USA |
|
Dr. Jan Hoflack, Chief Scientific and Operational Officer, Oncodesign SA, France |
|
Dr. Howard J. Federoff, Vice Chancellor of Health Affairs and Chief Executive Officer of Health System, University of California, Irvine, USA |
|
Dr. Litao Zhang, Vice President, Leads Discovery and Optimization, Bristol-Myers Squibb, USA |
|
Dr. Tom Mander, Chief Operating Officer, Domainex Ltd., UK |
|
Dr. Bruce Given, COO, Arrowhead Research Corporation, USA |
|
Dr. Chris H. Senanayake, Vice President, Boehringer Ingelheim Pharmaceuticals, Inc., USA |
|
Dr. Tina Tao, Head of APAC E2E Biodevelopment Center, Merck Group, China |
|
Dr. John Lambert, Corporate Vice President and Chief Medical Officer, PAREXEL International Shanghai, China |
|
Dr. Gerald J. Yakatan, Chairman & CEO, IriSys, LLC,.USA |
|
Dr. Akiyoshi Suganuma, Group Officer and President of BA-CFU, Medicine Development Center, Eisai Co., Ltd., Japan |
|
Dr. David C. Bunton, CEO, REPROCELL Europe Ltd., UK |
|
Dr. Steffen Denzinger, Director, Strategy and Business Development Process Solutions, Merck Millipore, Germany |
|
Dr. Eric Westhof, Academician, Vice President for Research and Doctoral Studies of the University of Strasbourg, France |
|
Dr. Wei Li, Professor and Director of UTCoP Drug Discovery Center, University of Tennessee Health Science Center, USA |
|
Dr. A. Vieira, Director, Metabolic Research Lab, Simon Fraser University, Canada |
|
Dr. Dieter Lubda, Head Actives Formulation RD Operations, Life Science | Process Solutions | Actives Formulation, Merck, Germany |
|
Dr. Jeffery Liu, Director, GSK, USA |
|
Dr. Guo-Ping Zhou, Adjunct Professor, Harvard Medical School, USA |
| Program Layout | |||
 Stream 0: Leadership Summit -Opening and Keynote Forum |
 Stream 1: Innovative Forum -Emerging Drug Targets |
 Stream 2: E-Symposia - Drug Design, Screening and Hit to Lead |
 Stream 3: Discovery Workshop - New Modalities of Medicinal Chemistry |
 Stream 4: X Lab -New Technologies and Processes of Drug Synthesis |
 Stream 5: Trial Center -ADMET in Medicinal Chemistry |
 Stream 6: P-Zone -Next Generation Drug Pipelines |
 Stream 7: S & T Hub - Research Frontiers and Tech Innovation |
 Stream 8: Training Camp - Training Courses |
 Stream 9: Showtime Square -Papers, Posters and Exhibition |
 Stream 10: Joint Events -Concurrent Conference |
 Stream 11: Joyful Commune -Social and Cultural Activities |
| Sponsors | Exhibitors |
|
● Sponsorship provides a great means of broadening your competitive edge by improving your company's image, prestige and credibility by supporting events that your target market finds attractive. |
● This conference provides your company with an unparalleled marketing opportunity to get before industry decision-makers. Exhibiting at the right exhibition can be one of the most efficient, effective and successful marketing activities available to you. |
| More | More |
Speaking Proposals are Now Being Accepted Call for Exhibitors and Sponsors Call for Collaborative Partners, Media and Journals
Jiangsu Pharmaceutical Association
Information Research Center of International Talent, SAFEA
 |
| BIT Group Global Ltd. |
BIT World Travel Service, Inc.
Copyright © 2009-2019, BIT Congress Inc.
Tel: 0086-411-84799609, Fax: 0086-411-84796897
Add: East Area, F11, Building 1, Dalian Ascendas IT Park, 1 Hui Xian Yuan, Dalian Hi-tech Industrial Zone, LN 116025, China